Erythropoietin, interleukin-3, interleukin-11, and GM-CSF in posttransplant erythrocytosis treated with enalapril.
Hu
R H
RH
Department of Surgery, National Taiwan University Hospital, Taipei, ROC.
Lee
P H
PH
Lee
C J
CJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004656:Enalapril / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood*; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D017370:Interleukin-11 / Q000097:blood*; D007377:Interleukin-3 / Q000097:blood*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011086:Polycythemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications; D012016:Reference Values; D012189:Retrospective Studies; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D006454:Hemoglobins; D017370:Interleukin-11; D007377:Interleukin-3; D004656:Enalapril; D016178:Granulocyte-Macrophage Colony-Stimulating Factor